Company Analysis

Filana Therapeutics, Inc. (FLNA)

Nasdaq: FLNA · Pharmaceutical Preparations · Austin, TX · filing with the SEC since 2000
Grade5.5
◀ Past 5.0● Present 4.0▶ Future 7.2
3 est.

Who runs Filana Therapeutics, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Barry Richard
President & CEO. First filing Jun 2021, latest Oct 1, 2026, 9 filings in all.
Officers reporting now
2
of 5 people with a filing in the last fifteen months
Directors reporting now
3
19 people on the record since 2006
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Barry RichardPresident & CEOJun 2021Oct 1, 2026none
Cook Robert ChristopherChief Operating & Legal OfficeOct 2022Oct 2, 2025none
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Quigley Jill M.directorNov 2026Nov 12, 2026none
Anderson Robert Eugene JrdirectorDec 2023Nov 25, 2025none
Bir Dawn CarterdirectorOct 2025Oct 22, 2025none
Earlier names on the record17, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton FLNA · research, not advice